AVXL today
$0.99-$0.07 (-6.66%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $1.41
Key levels
Resistance$1.29
Resistance$1.13
Latest news & SEC filings
SEC FilingAnavex Life Sciences Corp. filed an insider trading report (Form 4)
NewsAnavex Life Sciences picks Terrie Kellmeyer for top executive roles
All AVXL news →About Anavex Life Sciences
Anavex Life Sciences develops drug candidates aimed at disorders of the brain and nervous system. Its main experimental therapy, blarcamesine, works through sigma-1 receptor activation and is under study for Alzheimer's, a movement disorder known as Parkinson's, and Rett syndrome. The company also has additional compounds in earlier testing. Its trials have taken place in North America, Europe, and Australia, targeting patients with neurodegenerative and neurodevelopmental conditions.
Based on the company's 10-K filed Nov 25, 2025.
Nasdaq · Healthcare
ANAVEX LIFE SCIENCES CORP. (AVXL)
What Is the Price Target for AVXL?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is AVXL a Buy or Sell Right Now?
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for AVXL.
Start Free Trial →Is AVXL Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
P/B
Fair Value
$N/A
12
Moat Score
NONE
2/9
Piotroski Score
-0.3
Altman Z-Score
What Is Smart Money Doing with AVXL?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →AVXL Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-3.85%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for AVXL
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for AVXL, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 23:20:09 | $0.99 | 1,000 | $$990 | SELL |
| 22:48:14 | $0.99 | 4,000 | $$4K | SELL |
| 21:00:36 | $0.99 | 1,005 | $$994 | SELL |
| 20:59:37 | $0.99 | 1,006 | $$995 | BUY |
| 20:59:23 | $0.98 | 1,900 | $$2K | BUY |
5 dark pool trades shown · $$9K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for AVXL
PREVIEWSEPT Investing provides real-time options flow tracking for AVXL, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $2 | Jan 15 | 64 | $$480 | 8 | SWEEP |
| PUT | $2 | Jan 15 | 64 | $$60 | 1 | SWEEP |
| PUT | $2 | Jan 15 | 64 | $$60 | 1 | SWEEP |
| PUT | $2 | Jan 15 | 64 | $$60 | 1 | SWEEP |
| PUT | $2 | Jan 15 | 64 | $$120 | 2 | SWEEP |
5 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for ANAVEX LIFE SCIENCES CORP. (AVXL) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →AVXL — frequently asked questions
What is AVXL stock price today?
ANAVEX LIFE SCIENCES CORP. (AVXL) is at $0.99, down 6.66% (-$0.07) at the Nov 12, 2026 close.
Why is AVXL stock moving today?
Latest AVXL news — Nov 6, 2026: Anavex Life Sciences Corp. filed an insider trading report (Form 4) · Nov 3, 2026: Anavex Life Sciences picks Terrie Kellmeyer for top executive roles
What do analysts rate AVXL?
Analyst ratings for AVXL: 2 Buy, 0 Hold, 0 Sell — consensus Strong Buy.
Did AVXL beat earnings?
AVXL last reported on Aug 25, 2026: EPS $0.08 vs -$0.08 expected — a beat of 200.0%.
Does AVXL pay a dividend?
AVXL does not currently pay a dividend.
What are AVXL support and resistance levels?
Resistance: $1.13, $1.29, $1.41.
What are insiders doing with AVXL?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on AVXL?
Nov 6, 2026: Anavex Life Sciences Corp. filed an insider trading report (Form 4) · Nov 3, 2026: Anavex Life Sciences picks Terrie Kellmeyer for top executive roles